Filing Details
- Accession Number:
- 0001415889-24-024078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-27 19:32:58
- Reporting Period:
- 2024-09-27
- Accepted Time:
- 2024-09-27 19:32:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1817713 | Janux Therapeutics Inc. | JANX | Pharmaceutical Preparations (2834) | 822289112 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1864159 | Hollman Andrew Meyer | C/O Janux Therapeutics, Inc. 10955 Vista Sorrento Parkway, Suite 200 San Diego CA 92130 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-27 | 50,000 | $4.21 | 117,592 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-27 | 50,000 | $45.96 | 67,592 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-09-27 | 50,000 | $0.00 | 50,000 | $4.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 100,667 | 2031-03-09 | No | 4 | M | Direct |
Footnotes
- Includes 1,189 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on November 15, 2021, 1,752 shares acquired under the Plan on May 13, 2022, 2,401 shares acquired under the Plan on May 15, 2023 and 2,834 shares acquired under the Plan on May 15, 2024.
- The weighted average sale price for the transaction reported was $45.9551 and the range of prices were between $45.55 and $46.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- Immediately exercisable.
Billionaire Hedge Funds
